Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The combined formulation is designed to support comparative studies on synergistic effects in areas such as: Connective tissue and musculoskeletal repair mechanisms Gastrointestinal and mucosal integrity research Angiogenesis and vascular remodeling pathways Inflammatory response modulation Product Specifications Total peptide content per capsule: 500 mcg (BPC-157 + TB-500 blend) Capsule count : 50 Form: Enteric-coated research capsules for enhanced stability Purity : 99% (verified by independent third-party HPLC and mass spectrometry) Appearance : White to off-white powder encapsulated in size 0 vegetarian capsules Storage : Cool, dry place
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction
The estimated mean change in body weight at week 68 was 20.4% with CagriSema versus 3.0% with placebo (a difference of about 17 percentage points), and more CagriSema participants reached weight-loss thresholds of 5%, 20%, 25%, and 30% than placebo
You are not a lesser being than your doctor
The muscle-sparing effect represents a significant advantage for body recomposition goals
BPC-157 10mg A synthetic pentadecapeptide derived from a gastric protein, studied for its role in tissue repair signaling, NO system modulation, and VEGF pathway activity in controlled research environments
US$ 29.85
US$ 24.07
US$ 25.24
US$ 27.42
US$ 25.96
US$ 21.35
US$ 25.59
US$ 21.92
US$ 27.40